Indigo Diabetes
Signal active
Organization
Contact Information
Overview
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and now aims at transforming diabetes management.
About
Industries
Health Care, Medical, Medical Device, Diabetes
Founded
2016
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Indigo Diabetes headquartered in Europe, operates in the Health Care, Medical, Medical Device, Diabetes sector. The company focuses on Health Care and has secured $1.7B in funding across 32 round(s). With a team of 11-50 employees, Indigo Diabetes is actively contributing to advancements in Health Care. Their latest funding round, Series A - Indigo Diabetes, raised $7.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
9
Lead Investors
0
Total Funding Amount
$52.0M
Details
2
Indigo Diabetes has raised a total of $52.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 44.7M | ||
| 2016 | Early Stage Venture | 7.3M |
Investors
Indigo Diabetes is funded by 27 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| SoFi | - | FUNDING ROUND - SoFi | 7.3M |
| Manuardeo | - | FUNDING ROUND - Manuardeo | 7.3M |
| Indigo Diabetes | - | FUNDING ROUND - Indigo Diabetes | 7.3M |
| Capricorn Partners | - | FUNDING ROUND - Capricorn Partners | 7.3M |
Recent Activity
There is no recent news or activity for this profile.